FCR and Bevacizumab (FCR-B) Treatment in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Patients with relapsed chronic lymphocytic leukemia (CLL) often achieve response with chemoimmunotherapy but have short remission durations. Studies have shown that patients with CLL have increased angiogenesis in the microenvironment; levels of pro-angiogenic growth factors such as VEGF and/or angi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Jain, Preetesh, Lee, Hun Ju, Qiao, Wei, Wierda, William, Benjamini, Ohad, Burger, Jan, Ferrajoli, Alessandra, Estrov, Zeev, Kantarjian, Hagop, Keating, Michael, O’Brien, Susan
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221361/
https://ncbi.nlm.nih.gov/pubmed/25043749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28910
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados